BIOPHARMACOLOGICAL COMPOSITION COMPRISING COMPONENTS PRODUCED AND/OR SECRETED BY MESENCHYMAL STEM CELLS (MSC), WHICH ALLOWS THE RECOVERY OF TISSUE REGENERATIVE CAPACITY IN A SITUATION OF HEPATOSTEATOSIS OR WHEN THE ENDOGENOUS REGENERATIVE CAPACITY OF HEPATIC TISSUE IS INHIBITED

摘要

The invention relates to a biopharmacological composition comprising components produced and/or secreted by mesenchymal stem cells (MSC), preferably human, which allows the recovery of tissue regenerative capacity in a situation of hepatosteatosis.